Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2
Severe cases of COVID-19 continue to put pressure on medical operations by prolonging hospitalization, occupying intensive care beds, and forcing medical personnel to undergo harsh labor. The eradication of SARS-CoV-2 through vaccine development has yet to be achieved, mainly due to the appearance o...
Main Authors: | Toshifumi Osaka, Yoko Yamamoto, Takehisa Soma, Naoko Yanagisawa, Satoru Nagata |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/2/471 |
Similar Items
-
A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies
by: Yao Su, et al.
Published: (2018-12-01) -
A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
by: Longbo Hu, et al.
Published: (2023-07-01) -
Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
by: Animesh Sarker, et al.
Published: (2023-06-01) -
Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology
by: Lalita Priyamvada, et al.
Published: (2017-01-01) -
INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
by: A. I. Sushkov, et al.
Published: (2011-06-01)